Pancreaticoduodenectomy after downstaging of pancreatic carcinoma by chemotherapy

Case report OA: closed
⚙ AI-generated summary by qwen3.7-flash+body, 2026-09-24 ⓘ

The provided text does not contain an abstract or body content describing a study on endometriosis or adenomyosis, preventing the generation of a relevant summary.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-24 · read from full text ⓘ

This study evaluates the feasibility and outcomes of performing pancreaticoduodenectomy in patients with locally advanced pancreatic carcinoma who have undergone downstaging via chemotherapy. The research focuses on determining whether preoperative systemic treatment can render unresectable tumors operable, thereby improving surgical resectability rates and potentially extending patient survival. While the text provided consists primarily of reference citations rather than a full abstract or results section, the title indicates an investigation into neoadjuvant strategies for pancreatic cancer management. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,126 characters · extracted from oa-html · click to expand
Full Text The Full Text of this article is available as a PDF (119.5 KB). Selected References These references are in PubMed. This may not be the complete list of references from this article. - Anderson K. E., Spitz I. M., Sassa S., Bardin C. W., Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med. 1984 Sep 6;311(10):643–645. doi: 10.1056/NEJM198409063111006. [DOI] [PubMed] [Google Scholar] - Merk K., Björkholm M., Tullgren O., Mellstedt H., Holm G. Immune deficiency in family members of patients with Hodgkin's disease. Cancer. 1990 Nov 1;66(9):1938–1943. doi: 10.1002/1097-0142(19901101)66:93.0.co;2-o. [DOI] [PubMed] [Google Scholar] - Sparano J. A., Dutcher J. P., Kaleya R., Caliendo G., Fiorito J., Mitsudo S., Shechner R., Boley S. J., Gucalp R., Ciobanu N. Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer. 1991 Oct 1;68(7):1538–1544. doi: 10.1002/1097-0142(19911001)68:73.0.co;2-2. [DOI] [PubMed] [Google Scholar]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Adenocarcinoma Pancreatic Neoplasms Adenocarcinoma Adenocarcinoma Chemotherapy, Adjuvant Female Humans Middle Aged Pancreatic Neoplasms Pancreatic Neoplasms Pancreaticoduodenectomy

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T20:59:38.477535+00:00
unpaywall
last seen: 2026-10-24T06:30:43.844863+00:00